Stay updated on Durvalumab and Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.
Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a Locations section listing trial sites by US state and Canadian province (CA, CO, GA, IL, MD, MA, MO, NJ, PA, TN, WA; NB, ON, QC) and adjusted or removed prior location blocks. This clarifies where the study is conducted and where participants may enroll.SummaryDifference1%
- Check17 days agoChange DetectedRelated topics were added to the page: 'Multiple myeloma' and 'MedlinePlus Genetics', facilitating navigation to contextually related content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check25 days agoChange DetectedRelated topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the page. The change affects navigation context but not the study details or results.SummaryDifference0.1%
- Check39 days agoChange DetectedRevision: v3.3.2 updated from v3.2.0. This appears to be a minor, maintenance-related change with no visible edits to the study page.SummaryDifference0.0%
- Check46 days agoChange DetectedThe page now includes the 'Multiple myeloma' topic and related MedlinePlus Genetics links, and the funding-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check53 days agoChange DetectedThe page now omits the disease term 'Multiple Myeloma' and its genetics-related topics. This reduces the disease context and access to related resources on the study page.SummaryDifference0.1%
Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.